Id |
Subject |
Object |
Predicate |
Lexical cue |
T72 |
1-10 |
NN |
denotes |
prognosis |
T73 |
11-13 |
IN |
denotes |
of |
T74 |
14-22 |
NN |
denotes |
COVID-19 |
T75 |
24-25 |
IN |
denotes |
• |
T76 |
27-38 |
NNP |
denotes |
Tocilizumab |
T77 |
38-39 |
-COMMA- |
denotes |
, |
T78 |
40-42 |
DT |
denotes |
an |
T79 |
43-51 |
NN |
denotes |
anti-IL6 |
T80 |
51-52 |
-COMMA- |
denotes |
, |
T81 |
53-56 |
MD |
denotes |
can |
T82 |
57-63 |
VB |
denotes |
confer |
T83 |
64-71 |
NN |
denotes |
benefit |
T84 |
72-74 |
IN |
denotes |
in |
T85 |
75-83 |
NNS |
denotes |
patients |
R67 |
T72 |
T73 |
arg1Of |
prognosis,of |
R68 |
T74 |
T73 |
arg2Of |
COVID-19,of |
R69 |
T82 |
T75 |
arg1Of |
confer,• |
R70 |
T76 |
T77 |
arg1Of |
Tocilizumab,"," |
R71 |
T79 |
T77 |
arg2Of |
anti-IL6,"," |
R72 |
T79 |
T78 |
arg1Of |
anti-IL6,an |
R73 |
T82 |
T80 |
arg1Of |
confer,"," |
R74 |
T76 |
T81 |
arg1Of |
Tocilizumab,can |
R75 |
T82 |
T81 |
arg2Of |
confer,can |
R76 |
T76 |
T82 |
arg1Of |
Tocilizumab,confer |
R77 |
T83 |
T82 |
arg2Of |
benefit,confer |
R78 |
T82 |
T84 |
arg1Of |
confer,in |
R79 |
T85 |
T84 |
arg2Of |
patients,in |